Immune responses to infectious laryngotracheitis virus

Developmental and Comparative Immunology

Volumn 41, Issue 3, 2013, Pages 454-462

  Coppo, Mauricio J C ^a   Hartley, Carol A ^a   Devlin, Joanne M ^a  

^a THE UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Avian; Glycoprotein G; Herpesvirus; ILTV; Immunity

Indexed keywords

ILTOVIRUS VACCINE; THROMBOSPONDIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ALPHAHERPESVIRINAE; ARTICLE; AVIAN INFECTIOUS LARYNGOTRACHEITIS; CELLULAR IMMUNITY; CHICKEN; HUMORAL IMMUNITY; ILTOVIRUS; IMMUNOMODULATION; INFECTION CONTROL; INFECTION PREVENTION; INNATE IMMUNITY; NONHUMAN; POULTRY; PRIORITY JOURNAL;

AVES; GALLID HERPESVIRUS 1; GALLUS GALLUS; HERPESVIRIDAE;

AVIAN; CEO; CHICKEN EMBRYO ORIGIN; DIFFERENTIATION OF INFECTED AND VACCINATED ANIMALS; DIVA; ELISA; ELISPOT; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT; GB; GG; GLYCOPROTEIN B; GLYCOPROTEIN G; HERPES VIRUS OF TURKEYS; HERPESVIRUS; HVT; IBDV; IBV; ICP4; IL18; IL2; ILT; ILTV; IMMUNITY; INFECTED CELL PROTEIN 4; INFECTIOUS BRONCHITIS VIRUS; INFECTIOUS BURSAL DISEASE VIRUS; INFECTIOUS LARYNGOTRACHEITIS; INFECTIOUS LARYNGOTRACHEITIS VIRUS; INTERLEUKIN-18; INTERLEUKIN-2; MICRORNA; MIRNA; TCO; TISSUE CULTURE ORIGIN; VCKBP; VIRAL CHEMOKINE BINDING PROTEIN;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; GENE EXPRESSION REGULATION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, GALLID; HOST-PATHOGEN INTERACTIONS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; POULTRY DISEASES; RESPIRATORY SYSTEM; VACCINATION; VIRAL FUSION PROTEINS; VIRAL VACCINES; VIRULENCE;

EID: 84883053464     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2013.03.022     Document Type: Article

References (107)

1. Alcami A., Koszinowski U.H. Viral mechanisms of immune evasion. Mol. Med. Today 2000, 6:365-372.
2. Alcami A., Symons J.A., Khanna A. Poxviruses: capturing cytokines and chemokines. Semin. Virol. 1998, 5:419-427.
3. Andreasen J.R., Glisson J.R., Goodwin M.A., Resurreccion R.S., Villegas P., Brown J. Studies of infectious laryngotracheitis vaccines: immunity in layers. Avian Dis. 1989, 33:524-530.
4. Bagust T.J. Laryngotracheitis (Gallid-1) herpesvirus infection in the chicken 4. Latency establishment by wild and vaccine strains of ILT virus. Avian Pathol. 1986, 15:581-595.
5. Bagust T.J., Johnson M.A. Avian infectious laryngotracheitis: virus-host interactions in relation to prospects of eradication. Avian Pathol. 1995, 24:373-391.
6. Bagust T.J., Calnek B.W., Fahey K.J. Gallid-1 Herpesvirus infection in the chicken. 3. Reinvestigation of the pathogenesis of infectious laryngotracheitis in acute and early post-acute respiratory disease. Avian Dis. 1986, 30:179-190.
7. Bauer B., Lohr J.E., Kaleta E.F. Comparison of commercial ELISA test kits from Australia and the USA with the serum neutralization test in cell cultures for the detection of antibodies to the infectious laryngotracheitis virus of chickens. Avian Pathol. 1999, 28:65-72.
8. Blacker H., Kirkpatrick N., Rubite A., O'Rourke D., Noormohammadi A.H. Epidemiology of recent outbreaks of infectious laryngotracheitis in poultry in Australia. Aust. Vet. J. 2011, 89:89-94.
9. Bryant N.A., Davis-Poynter N., Vanderplasschen A., Alcami A. Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J. 2003, 22:833-846.
10. Callison S.A., Riblet S.M., Oldoni I., Sun S., Zavala G., Williams S., Resurreccion R.S., Spackman E., Garcia M. Development and validation of a real-time Taqman (R) PCR assay for the detection and quantification of infectious laryngotracheitis virus in poultry. J. Virol. Methods 2007, 139:31-38.
11. Calnek B.W., Fahey K.J., Bagust T.J. In vitro infection studies with infectious laryngotracheitis virus. Avian Dis. 1986, 30:327-336.
12. Chang P.W., Sculco F., Yates V.J. An in vivo and in vitro study of infectious laryngotracheitis virus in chicken leukocytes. Avian Dis. 1977, 21:492-500.
13. Chen H.-Y., Cui P., Cui B.-A., Li H.-P., Jiao X.-Q., Zheng L.-L., Cheng G., Chao A.-J. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing glycoprotein B of infectious laryngotracheitis virus and chicken IL-18. FEMS Immunol. Med. Microbiol. 2011, 63:289-295.
14. Chen H.Y., Zhang H.Y., Li X.S., Cui B.A., Wang S.J., Geng J.W., Li K. Interleukin-18-mediated enhancement of the protective effect of an infectious laryngotracheitis virus glycoprotein B plasmid DNA vaccine in chickens. J. Med. Microbiol. 2011, 60:110-116.
15. Cone R.A. Barrier properties of mucus. Adv. Drug Delivery. Rev. 2009, 61:75-85.
16. Coppo M.J.C., Noormohammadi A.H., Hartley C.A., Gilkerson J.R., Browning G.F., Devlin J.M. Comparative in vivo safety and efficacy of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye-drop. Avian Pathol. 2011, 40:411-417.
17. Coppo M.J.C., Devlin J.M., Noormohammadi A.H. Comparison of the replication and transmissibility of two infectious laryngotracheitis virus chicken embryo origin vaccines delivered via drinking-water. Avian Pathol. 2012, 41:195-202.
18. Coppo M.J.C., Devlin J.M., Noormohammadi A.H. Comparison of the transmissibility and replication of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water. Avian Pathol. 2012, 41:99-106.
19. Creelan J.L., Calvert V.M., Graham D.A., McCullough S.J. Rapid detection and characterization from field cases of infectious laryngotracheitis virus by real-time polymerase chain reaction and restriction fragment length polymorphism. Avian Pathol. 2006, 35:173-179.
20. Davison A.J. Herpesvirus systematics. Vet. Microbiol. 2010, 143:52-69.
21. Davison S., Gingerich E.N., Casavant S., Eckroade R.J. Evaluation of the efficacy of a live fowlpox-vectored infectious laryngotracheitis/avian encephalomyelitis vaccine against ILT viral challenge. Avian Dis. 2006, 50:50-54.
22. 3-interferon assay and other ancillary diagnostic techniques. Res. Vet. Sci. 2006, 81:190-210.
23. Devlin J.M., Browning G.F., Hartley C.A., Kirkpatrick N.C., Mahmoudian A., Noormohammadi A.H., Gilkerson J.R. Glycoprotein G is a virulence factor in infectious laryngotracheitis virus. J. Gen. Virol. 2006, 87:2839-2847.
24. Devlin J.M., Browning G.F., Hartley C.A., Gilkerson J.R. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine. Vaccine 2007, 25:3561-3566.
25. Devlin J.M., Browning G.F., Gilkerson J.R., Fenton S.P., Hartley C.A. Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol. Avian Pathol. 2008, 37:83-88.
26. Devlin J.M., Viejo-Borbolla A., Browning G.F., Noormohammadi A.H., Gilkerson J.R., Alcami A., Hartley C.A. Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus. Vaccine 2010, 28:1325-1332.
27. Devlin J.M., Hartley C.A., Gilkerson J.R., Coppo M.J., Vaz P., Noormohammadi A.H., Browning G.F. Horizontal transmission dynamics of a glycopotein G defficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus. Vaccine 2011, 29:5699-5704.
28. Diallo I.S., Taylor J., Gibson J., Hoad J., de Jong A., Hewitson G., Corney B.G., Rodwell B.J. Diagnosis of a naturally occurring dual infection of layer chickens with fowlpox virus and gallid herpesvirus 1 (infectious laryngotracheitis virus). Avian Pathol. 2010, 39:25-30.
29. Dufour-Zavala L. Epizootiology of infectious laryngotracheitis and presentation of an industry control program. Avian Dis. 2008, 52:1-7.
30. Fahey K.J., York J.J. The role of mucosal antibody in immunity to infectious laryngotracheitis virus in chickens. J. Gen. Virol. 1990, 71:2401-2405.
31. Fahey K.J., York J.J. The role of mucosal antibody in immunity to infectious laryngotracheitis virus in chickens. J. Gen. virol. 1990, 71(Pt 10):2401-2405.
32. Fahey K.J., Bagust T.J., York J.J. Laryngotracheitis herpesvirus infection in the chicken: the role of humoral antibody in immunity to a graded challenge infection. Avian Pathol. 1983, 12:505-514.
33. Fahey K.J., Bagust T.J., York J.J. Laryngotracheitis herpesvirus infection in the chicken: the role of humoral antibody in immunity to a graded challenge infection. Avian Pathol. 1983, 12:505-514.
34. Fahey K.J., York J.J., Bagust T.J. Laryngotracheitis herpesvirus infection in the chicken. II. The adoptive transfer of resistance with immune spleen cells. Avian Pathol. 1984, 13:265-275.
35. Fuchs W., Wiesner D., Veits J., Teifke J.P., Mettenleiter T.C. In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs. J. Virol. 2005, 79:705-716.
36. Fuchs W., Veits J., Helferich D., Granzow H., Teifke J.P., Mettenleiter T.C. Molecular biology of avian infectious laryngotracheitis virus. Vet. Res. 2007, 38:261-279.
37. Fulton R.M., Schrader D.L., Will M. Effect of route of vaccination on the prevention of infectious laryngotracheitis in commercial egg-laying chickens. Avian Dis. 2000, 44:8-16.
38. García, M., Mashchenko, A., Riblet, S.M., Mundt, A., Mundt, E., 2012. Replication and protection induced by infectious laryngotracheitis glycoprotein J deletion mutant in commercial broilers. In: 9th International symposium on Marek's disease and avian herpesviruses, Berlin, Germany, p. 46.
39. Gelenczei E.F., Marty E.W. Strain stability and immunologic characteristics of a tissue-culture modified infectious laryngotracheitis virus. Avian Dis. 1965, 9:44-56.
40. Gimeno I.M., Cortes A.L., Guy J.S., Turpin E., Williams C. Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination. Avian Pathol. 2011, 40:395-403.
41. Guy J., García M. Laryngotracheitis. Diseases of Poultry 2008, 137-152. Blackwell Publishing, Ames. 12 ed. Y.M. Saif, A.M. Fadly, J.R. Glisson, L.L. McDougald, L.K. Nolan, D.E. Swayne (Eds.).
42. Guy J.S., Barnes H.J., Morgan L.M. Virulence of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates. Avian Dis. 1990, 34:106-113.
43. Guy J.S., Barnes J.H., Smith L. Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Dis. 1991, 35:348-355.
44. Guy, J.S., Gimeno, I., West, M., 2010a. Experimental evaluation of in ovo-administered virus-vectored laryngotracheitis virus vaccines for prevention of disease in broiler chickens. In: 2010 AAAP Annual Meeting, Atlanta, GA, United States of America.
45. Guy, J.S., Gimeno, I.M., West, M., 2010b. Recombinant laryngotracheitis virus vaccines: evaluation of effectiveness for prevention of disease in commercial broiler chickens, Project report. Department of Population Health and Pathobiology, North Carolina State University College of veterinary Medicine, Raleigh, North Carolina, pp. 1-17.
46. Han M.G., Kweon C.H., Mo I.P., Kim S.J. Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene. Arch. Virol. 2002, 147:1017-1031.
47. Hayashi S., Odagiri Y., Kotani T., Horiuchi T. Pathological changes of tracheal mucosa in chickens infected with infectious laryngotracheitis virus. Avian Dis. 1985, 29:943-950.
48. Hayles L.B., Hamilton D., Newby W.C. Transfer of parental immunity to infectious laryngotracheitis in chicks. Can. J. Comp. Med. 1976, 40:218-219.
49. Hayles L.B., Newby W.C., Gasperdone H., Gilchrist E.W. Immunization of broiler chickens with a commercial infectious laryngotracheitis vaccine in the drinking water. Can. J. Comp. Med. 1976, 40:129-134.
50. Helferich D., Veits J., Teifke J.P., Mettenleiter T.C., Fuchs W. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens. J. Gen. Virol. 2007, 88:732-742.
51. Hilton L.S., Bean A.G.D., Kimpton W.G., Lowenthal J.W. Interleukin-2 directly induces activation and proliferation of chicken T cells in vivo. J. Interferon Cytokine Res. 2002, 22:755-763.
52. Honda T., Okamura H., Taneno A., Yamada S., Takahashi E. The role of cell-mediated immunity in chickens inoculated with the cell-associated vaccine of attenuated infectious laryngotracheitis virus. J. Vet. Med. Sci. 1994, 56:1051-1055.
53. Honda T., Taneno A., Sakai E., Yamada S., Takahashi E. Immune response and in vivo distribution of the virus in chickens inoculated with the cell-associated vaccine of attenuated infectious laryngotracheitis (ILT) virus. J. Vet. Med. Sci. 1994, 56:691-695.
54. Hughes C.S., Gaskell R.M., Jones R.C., Bradbury J.M., Jordan F.T.W. Effects of certain stress factors on the re-excretion of infectious laryngotracheitis virus from latently infected carrier birds. Res. Vet. Sci. 1989, 46:274-276.
55. Hughes C.S., Williams R.A., Gaskell R.M., Jordan F.T.W., Bradbury J.M., Bennet M., Jones R.C. Latency and reactivation of infectious laryngotracheitis vaccine virus. Arch. Virol. 1991, 121:213-218.
56. Johnson M.A., Tyack S.G., Prideaux C., Kongsuwan K., Sheppard M. Nucleotide sequence of infectious laryngotracheitis virus (gallid herpesvirus 1) ICP4 gene. Virus Res. 1995, 35:193-204.
57. Johnson D.I., Vagnozzi A., Dorea F., Riblet S.M., Mundt A., Zavala G., García M. Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines. Avian Dis. 2010, 54:1251-1259.
58. Jordan F.T.W. Immunity to infectious laryngotracheitis. 16th Poultry Science Symposium 1981, 245-254. British Poultry Science Ltd., Edinburgh, United Kingdom. M.E. Rose, L.N. Payne, B.M. Freeman (Eds.).
59. Jordan F.T.W. Immunity to infectious laryngotraheitits virus. Avian Immunology 1981, British Poultry Science Ltd., Edinburgh. M.E. Ross, L.N. Payne, B.M. Freeman (Eds.).
60. Kirkpatrick N.C., Mahmoudian A., Colson C.A., Devlin J.M., Noormohammadi A.H. Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis. Avian Pathol. 2006, 35:449-453.
61. Kongsuwan K., Johnson M.A., Prideaux C.T., Sheppard M. Identification of an infectious laryngotracheitis virus gene encoding an immunogenic protein with a predicted M(r) of 32kilodaltons. Virus Res. 1993, 29:125-140.
62. Lee J.Y., Joon Jin S., Ann W., Xianyao L., Huaijun Z., Bottje W.G., Byung-Whi K. Transcriptional profiling of host gene expression in chicken embryo lung cells infected with laryngotracheitis virus. BMC Genomics 2010, 11:445-459.
63. Lee J., Bottje W.G., Kong B.-W. Genome-wide host responses against infectious laryngotracheitis virus vaccine infection in chicken embryo lung cells. BMC Genomics 2012, 13:143.
64. Lee S.-W., Markham P.F., Coppo M.J.C., Legione A.R., Markham J.F., Noormohammadi A.H., Browning G.F., Ficorilli N., Hartley C.A., Devlin J.M. Attenuated animal vaccines have recombined to form virulent field viruses. Science 2012, 337:188.
65. Legione A.R., Coppo M.J.C., Lee S.-W., Noormohammadi A.H., Hartley C.A., Browning G.F., Gilkerson J.R., O'Rourke D., Devlin J.M. Safety and vaccine efficacy of a glycoprotein G defficient strain of infectious laryngotracheitis virus delivered in ovo. Vaccine 2012, 30:7193-7198.
66. Mahmoudian A., Kirkpatrick N.C., Coppo M., Lee S.-W., Devlin J.M., Markham P.F., Browning G.F., Noormohammadi A.H. Development of a SYBR Green quantitative polymerase chain reaction assay for rapid detection and quantification of infectious laryngotracheitis virus. Avian Pathol. 2011, 40:237-242.
67. Mebatsion, T., Melson, L., Hein, R., 2008. A novel HVT-based recombinant vaccine (Innovax-ILT) to simultaneously control infectious laryngotracheitis and Marek's disease in chickens. In: XXIII World's Poultry Conference, Brisbane, Queensland, Australia, pp. 42-44.
68. Mundt, A., Mundt, E., García, M., 2010. Generation of a glycoprotein J deletion mutant of infectious laryngotracheitis virus (ILTV) as potential vaccine for DIVA approach. In: 2010 AAAP Annual meeting, Atlanta GA, United States of America, p. 2954.
69. Nakamichi K., Matsumoto Y., Otsuka H. Bovine herpesvirus 1 glycoprotein G is necessary for maintaining cell-to-cell junctional adherence among infected cells. Virology 2002, 294:22-30.
70. Neff C., Suddler C., Hoop R.K. Characterization of western European field isolates and vaccine strains of avian infectious laryngotracheitis virus by restriction fragment length polymorphism and sequence analysis. Avian Dis. 2008, 52:278-283.
71. Ojkic D., Swinton J., Vallieres M., Martin E., Shapiro J., Sanei B., Binnington B. Characterization of field isolates of infectious laryngotracheitis from Ontario. Avian Pathol. 2006, 35:286-292.
72. Oldoni I., García M. Characterization of infectious laryngotracheitis virus isolates from the United States by polymerase chain reaction and restriction fragment length polymorphism of multiple genome regions. Avian Pathol. 2007, 36:167-176.
73. Oldoni I., Rodriguez-Avila A., Riblet S., Garcia M. Characterization of infectious laryngotracheitis virus (ILTV) isolates from commercial poultry by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Avian Dis. 2008, 52:59-63.
74. Oldoni I., Rodriguez-Avila A., Riblet S., Zavala G., Garcia M. Pathogenicity and growth characteristics of selected infectious laryngotracheitis virus strains from the United States. Avian Pathol. 2009, 38:47-53.
75. Parry C.M., Simas J.P., Smith V.P., Stewart C.A., Minson A.C., Efstathiou S., Alcami A. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 2000, 191:573-578.
76. Pavlova S.P., Veits J., Blohm U., Maresch C., Mettenleiter T.C., Fuchs W. In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus. J. Gen. Virol. 2010, 91:847-857.
77. Peters M.A., Browning G.F., Washington E.A., Crabb B.S., Kaiser P. Embryonic age influences the capacity for cytokine induction in chicken thymocytes. Immunology 2003, 110:358-367.
78. Pomorska-Mól M., Markowska-Daniel I. Interferon-γ secretion and proliferative responses of peripheral blood mononuclear cells after vaccination of pigs against Aujeszky's disease in the presence of maternal immunity. FEMS Immunol. Med. Microbiol. 2010, 58:405-411.
79. Posavad C.M., Magaret A.S., Zhao L., Mueller D.E., Wald A., Corey L. Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2. Vaccine 2011, 29:7058-7066.
80. Poulsen D.J., Thureen D.R., Keeler C.L. Research notes: comparison of disease susceptibility and resistance in three lines of chickens experimentally infected with infectious laryngotracheitis virus. Poult. Sci. 1998, 77:17-21.
81. Purcell D.A. The ultrastructural changes produced by infectious laryngotracheitis virus in tracheal epithelium of the fowl. Res. Vet. Sci. 1971, 12:455458.
82. Robertson G.M., Egerton J.R. Replication of laryngotracheitis virus in chickens following vaccination. Aust. Vet. J. 1981, 57:119-123.
83. Rodriguez-Avila A., Oldoni I., Riblet S., García M. Replication and transmission of live attenuated infectious laryngotracheitis virus (ILTV) vaccines. Avian Dis. 2007, 51:905-911.
84. Rodriguez-Avila A., Oldoni I., Riblet S., García M. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States. Avian Pathol. 2008, 37:287-292.
85. Roizman B., Sears A. Herpes simplex viruses and their replication. Fields Virology 1996, Lippincott Williams and Wilkins, Philadelphia. 4 ed. B. Fields, P. Howley, D. Knipe (Eds.).
86. Ruiz-Arguello M.B., Smith V.P., Campanella G.S., Baleux F., Arenzana-Seisdedos F., Luster A.D., Alcami A. An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. J. Virol. 2008, 82:917-926.
87. Samberg Y., Aronovici I. The development of a vaccine against avian infectious laryngotracheitis. 1. Modification of a laryngotracheitis virus. Refuah Veterinarith 1969, 26:54-59.
88. Sander J.E., Thayer S.G. Evaluation of ELISA titres to infectious laryngotracheitis. Avian Dis. 1997, 41:429-432.
89. Schnitzlein W.M., Winans R., Ellsworth S., Tripathy D.N. Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus. Virology 1995, 209:304-314.
90. Shil N.K., Markham P.F., Noormohammadi A.H., O'Rourke D., Devlin J.M. Development of an enzyme-linked immunosorbent assay to detect chicken serum antibody to glycoprotein G of infectious laryngotracheitis virus. Avian Dis. 2012, 56:509-515.
91. Sun H.-L., Wang Y.-F., Tong G.-Z., Zhang P.-J., Miao D.-Y., Zhi H.-D., Wang M., Wang M. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus. Avian Dis. 2008, 52:111-117.
92. Tarpey I., Davis P.J., Sondermeijer P., van Geffen C., Verstegen I., Schijns V.E.J.C., Kolodsick J., Sundick R. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge. Avian Pathol. 2007, 36:69-74.
93. Tarpey I., van Loon A.A., de Haas N., Davis P.J., Orbell S., Cavanagh D., Britton P., Casais R., Sondermeijer P., Sundick R. A recombinant turkey herpesvirus expressing chicken interleukin-2 increases the protection provided by in ovo vaccination with infectious bursal disease and infectious bronchitis virus. Vaccine 2007, 25:8529-8535.
94. Tong G.-Z., Zhang S.-J., Meng S.-S., Wang L., Qiu H.-J., Wang Y.-F., Wang M. Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathol. 2001, 30:143-148.
95. Tran L.C., Kissner J.M., Westerman L.E., Sears A.E. A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1818-1822.
96. Tripathy D.N. Infectious laryngotracheitis. A laboratory Manual for the Isolation and Identification of Avian Pathogens 1998, 111-115. International Book Distributing Co. and American Association of Avian Pathologists (USA), Charbagh, Lucknow (India). fourth ed. D.E. Swayne, J.R. Glisson, M.W. Jackwood, J.E. Pearson, W.M. Reed (Eds.).
97. Vagnozzi A., García M., Riblet S.M., Zavala G. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines. Avian Dis. 2010, 54:1210-1219.
98. Vagnozzi A., Zavala G., Riblet S.M., Mundt A., García M. Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotraqueitis virus in broiler chickens. Avian Pathol. 2012, 41:21-31.
99. van Berkel V., Barrett J., Tiffany H.L., Fremont D.H., Murphy P.M., McFadden G., Speck S.H., Virgin H.I. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 2000, 74:6741-6747.
100. Vareille M., Kieninger E., Edwards M.R., Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 2011, 24:210-229.
101. Veits J., Lüschow D., Kindermann K., Werner O., Teifke J.P., Mettenleiter T.C., Fuchs W. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J. Gen. Virol. 2003, 84:3343-3352.
102. Waidner L.A., Morgan R.W., Anderson A.S., Bernberg E.L., Kamboj S., García M., Riblet S.M., Ouyang M., Isaacs G.K., Markis M., Meyers B.C., Green P.J., Burnside J. MicroRNAs of Gallid and Meleagridis herpesviruses show generally conserved genomic locations and are virus-specific. Virology 2009, 388:128-136.
103. Waidner L.A., Burnside J., Anderson A.S., Bernberg E.L., German M.A., Meyers B.C., Green P.J., Morgan R.W. A microRNA of infectious laryngotracheitis virus can downregulate and direct cleavage of ICP4 mRNA. Virology 2011, 411:25-31.
104. Williams R.A., Bennet M., Bradbury J.M., Gaskell R.M., Jones R.C., Jordan F.T.W. Demonstration of sites of latency of infectious laryngotracheitis virus using the polymerase chain reaction. J. Gen. Virol. 1992, 73:2415-2420.
105. Wilsonu A., Corthésyu P., Reichenbachu P., MacDonaldu H.R., Nabholz M. Interleukins (IL)-1 and IL-2 control IL-2 receptor α and β expression in immature thymocytes. Eur. J. Immunol. 1994, 24:1729-1735.
106. York J.J., Fahey K.J. Humoral and cell-mediated immune responses to the glycoproteins of infectious laryngotracheitis herpesvirus. Arch. Virol. 1990, 115:289-297.
107. York J.J., Fahey K.J. Vaccination with affinity-purified glycoproteins protects chickens against infectious laryngotracheitis herpesvirus. Avian Pathol. 1991, 20:693-704.